Concord Biotech Ltd
NSE: CONCORDBIO BSE: 543960
₹1092.30
(-0.79%)
Wed, 25 Mar 2026, 04:58 pm
Market Cap114.29B
PE Ratio36.57
Dividend0.98
Commercial Services
Miscellaneous Commercial Services
24.5KConcord Biotech Income Statement
| Particulars | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total revenue | 4.98B | 6.04B | 7.08B | 8.31B | 9.98B | 11.80B |
| Gross profit | 2.17B | 3.24B | 2.99B | 3.71B | 4.72B | 5.54B |
| Operating expenses (excl. COGS) | -338.68M | -304.57M | -750.25M | -921.83M | -1.06B | -1.13B |
| Selling/general/admin expenses, total | -302.52M | -277.67M | -635.64M | -880.43M | -975.47M | -1.15B |
| Research & development | -157.76M | -172.34M | -258.47M | -277.59M | -209.84M | -255.08M |
| Selling/general/admin expenses, other | -144.76M | -105.32M | -377.17M | -602.84M | -765.62M | -898.97M |
| Other operating expenses, total | -36.16M | -26.90M | -114.61M | -41.40M | -85.20M | 27.32M |
| Operating income | 1.83B | 2.93B | 2.24B | 2.79B | 3.66B | 4.41B |
| Non-operating income, total | 303.01M | 201.00M | 168.99M | 411.95M | 435.37M | 545.16M |
| Interest expense, net of interest capitalized | -11.67M | -9.05M | -61.35M | -91.33M | -31.26M | -10.42M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 424.50M | 207.86M | 225.95M | 497.08M | 465.21M | 555.57M |
| Non-operating interest income | 409.00K | 15.73M | 47.87M | 44.41M | 30.41M | 16.48M |
| Miscellaneous non-operating expense | 424.09M | 192.13M | 178.08M | 452.67M | 434.80M | 539.09M |
| Unusual income/expense | -109.81M | 2.19M | 4.39M | 6.21M | 1.41M | 9.00K |
| Pretax income | 2.13B | 3.13B | 2.41B | 3.20B | 4.09B | 4.96B |
| Taxes | -445.26M | -778.33M | -625.89M | -819.28M | -1.04B | -1.23B |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 1.69B | 2.35B | 1.75B | 2.40B | 3.08B | 3.72B |
| Net income | 1.69B | 2.35B | 1.75B | 2.40B | 3.08B | 3.72B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 1.69B | 2.35B | 1.75B | 2.40B | 3.08B | 3.72B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - |
| EBITDA | 2.04B | 3.21B | 2.74B | 3.33B | 4.19B | 4.96B |
| EBIT | 1.83B | 2.93B | 2.24B | 2.79B | 3.66B | 4.41B |
| Total operating expenses | -3.15B | -3.10B | -4.84B | -5.52B | -6.32B | -7.38B |
| Prepaid expenses | 40.23M | 45.44M | 47.61M | 55.19M | 73.31M | 73.91M |
| Deferred income, current | 197.34M | 28.16M | 155.52M | 28.68M | 36.62M | 84.05M |
| Capital and operating lease obligations | 16.33M | 16.33M | 3.11M | 1.64M | 18.87M | 6.30M |
| Operating lease liabilities | — | — | — | — | — | — |
| Deferred tax liabilities | 157.21M | 180.52M | 229.18M | 256.22M | 305.16M | 381.54M |
| Deferred income, non-current | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — |
| Common dividends paid | -805.45M | -57.06M | -705.21M | -535.63M | -714.53M | -915.39M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800